Bone Disease in Multiple Myeloma: Biologic and Clinical Implications
Multiple Myeloma (MM) is a hematologic malignancy characterized by the proliferation of monoclonal plasma cells localized within the bone marrow. Bone disease with associated osteolytic lesions is a hallmark of MM and develops in the majority of MM patients. Approximately half of patients with bone...
Main Authors: | Zachary S. Bernstein, E. Bridget Kim, Noopur Raje |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/11/15/2308 |
Similar Items
-
Differences in interactions with the bone microenvironment between solid tumors and multiple myeloma: pathogenetic aspects. Possibilities and effectiveness of osteomodifying agents in multiple myeloma
by: A. V. Snegovoy, et al.
Published: (2021-04-01) -
Treatment of bone complications in multiple myeloma patients
by: V. V. Ptushkin
Published: (2022-11-01) -
Management of bone metastasis and cancer treatment-induced bone loss during the COVID-19 pandemic: An international perspective and recommendations
by: J.E. Brown, et al.
Published: (2021-08-01) -
Comparison of denosumab and zoledronic acid for the treatment of solid tumors and multiple myeloma with bone metastasis: a systematic review and meta-analysis based on randomized controlled trials
by: Lianghai Jiang, et al.
Published: (2021-06-01) -
Management of Myeloma Bone Lesions
by: Jeng-Shiun Du, et al.
Published: (2021-03-01)